196 related articles for article (PubMed ID: 37160439)
21. Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine.
Kroiss A; Putzer D; Uprimny C; Decristoforo C; Gabriel M; Santner W; Kranewitter C; Warwitz B; Waitz D; Kendler D; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2011 May; 38(5):865-73. PubMed ID: 21279352
[TBL] [Abstract][Full Text] [Related]
22.
AlSadi R; Maaz AUR; Bouhali O; Djekidel M
J Nucl Med Technol; 2023 Jun; 51(2):140-146. PubMed ID: 37192823
[No Abstract] [Full Text] [Related]
23. Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter.
Zhang H; Huang R; Pillarsetty N; Thorek DL; Vaidyanathan G; Serganova I; Blasberg RG; Lewis JS
Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):322-32. PubMed ID: 24173571
[TBL] [Abstract][Full Text] [Related]
24. Benign differentiation of treated neuroblastoma as a cause of false positive by
Garcia JR; Bassa P; Soler M; Jaramillo A; Ortiz S; Riera E
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(6):389-390. PubMed ID: 31000447
[No Abstract] [Full Text] [Related]
25. 124I-MIBG: a new promising positron-emitting radiopharmaceutical for the evaluation of neuroblastoma.
Cistaro A; Quartuccio N; Caobelli F; Piccardo A; Paratore R; Coppolino P; Sperandeo A; Arnone G; Ficola U
Nucl Med Rev Cent East Eur; 2015; 18(2):102-6. PubMed ID: 26315872
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy.
Dhull VS; Sharma P; Patel C; Kundu P; Agarwala S; Bakhshi S; Bhatnagar V; Bal C; Kumar R
Nucl Med Commun; 2015 Oct; 36(10):1007-13. PubMed ID: 26049371
[TBL] [Abstract][Full Text] [Related]
27. Combining 123I-metaiodobenzylguanidine SPECT/CT and 18F-FDG PET/CT for the assessment of brown adipose tissue activity in humans during cold exposure.
Admiraal WM; Holleman F; Bahler L; Soeters MR; Hoekstra JB; Verberne HJ
J Nucl Med; 2013 Feb; 54(2):208-12. PubMed ID: 23318291
[TBL] [Abstract][Full Text] [Related]
28.
Turnock S; Turton DR; Martins CD; Chesler L; Wilson TC; Gouverneur V; Smith G; Kramer-Marek G
Sci Rep; 2020 Dec; 10(1):20918. PubMed ID: 33262374
[TBL] [Abstract][Full Text] [Related]
29. Nuclear Medicine Imaging in Neuroblastoma: Current Status and New Developments.
Samim A; Tytgat GAM; Bleeker G; Wenker STM; Chatalic KLS; Poot AJ; Tolboom N; van Noesel MM; Lam MGEH; de Keizer B
J Pers Med; 2021 Apr; 11(4):. PubMed ID: 33916640
[TBL] [Abstract][Full Text] [Related]
30. Predicting event-free survival after induction of remission in high-risk pediatric neuroblastoma: combining
Feng L; Yang X; Wang C; Zhang H; Wang W; Yang J
Pediatr Radiol; 2024 May; 54(5):805-819. PubMed ID: 38492045
[TBL] [Abstract][Full Text] [Related]
31. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
Rufini V; Treglia G; Castaldi P; Perotti G; Calcagni ML; Corsello SM; Galli G; Fanti S; Giordano A
Nucl Med Commun; 2011 Jul; 32(7):575-82. PubMed ID: 21471850
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of ¹⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma.
Piccardo A; Puntoni M; Lopci E; Conte M; Foppiani L; Sorrentino S; Morana G; Naseri M; Cistaro A; Villavecchia G; Fanti S; Garaventa A
Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1046-56. PubMed ID: 24562643
[TBL] [Abstract][Full Text] [Related]
33. 123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.
Sharp SE; Shulkin BL; Gelfand MJ; Salisbury S; Furman WL
J Nucl Med; 2009 Aug; 50(8):1237-43. PubMed ID: 19617326
[TBL] [Abstract][Full Text] [Related]
34. Compared to
Kroiss AS; Uprimny C; Shulkin BL; Frech A; Tilg H; Gasser RW; Sprinzl GM; Gruber L; Thomé C; Plangger C; Url C; Fraedrich G; Virgolini IJ
Ann Nucl Med; 2017 Jun; 31(5):357-365. PubMed ID: 28349331
[TBL] [Abstract][Full Text] [Related]
35. Comparison of diagnosing and staging accuracy of PET (CT) and MIBG on patients with neuroblastoma: Systemic review and meta-analysis.
Xia J; Zhang H; Hu Q; Liu SY; Zhang LQ; Zhang A; Zhang XL; Wang YQ; Liu AG
J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):649-660. PubMed ID: 29058276
[TBL] [Abstract][Full Text] [Related]
36. A Prospective Comparative Study of 18 F-FDOPA PET/CT Versus 123 I-MIBG Scintigraphy With SPECT/CT for the Diagnosis of Pheochromocytoma and Paraganglioma.
Sung C; Lee HS; Lee DY; Kim YI; Kim JE; Lee SJ; Oh SJ; Sung TY; Lee YM; Kim YH; Kim BJ; Koh JM; Lee SH; Ryu JS
Clin Nucl Med; 2024 Jan; 49(1):27-36. PubMed ID: 38054497
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and evaluation of 4-[18F]fluoropropoxy-3-iodobenzylguanidine ([18F]FPOIBG): A novel 18F-labeled analogue of MIBG.
Vaidyanathan G; McDougald D; Koumarianou E; Choi J; Hens M; Zalutsky MR
Nucl Med Biol; 2015 Aug; 42(8):673-84. PubMed ID: 25956997
[TBL] [Abstract][Full Text] [Related]
38. Technical Note: Simplified and practical pretherapy tumor dosimetry - A feasibility study for
Seo Y; Huh Y; Huang SY; Hernandez-Pampaloni JM; Hawkins RA; Gustafson WC; Vo KT; Matthay KK
Med Phys; 2019 May; 46(5):2477-2486. PubMed ID: 30761545
[TBL] [Abstract][Full Text] [Related]
39. Roles of PET/Computed Tomography in the Evaluation of Neuroblastoma.
Wen Z; Zhang L; Zhuang H
PET Clin; 2020 Jul; 15(3):321-331. PubMed ID: 32498988
[TBL] [Abstract][Full Text] [Related]
40. Comparative Role of
Hemrom A; Arora G; Damle NA; Bal C
Nucl Med Mol Imaging; 2022 Oct; 56(5):236-244. PubMed ID: 36310834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]